NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Navidea Biopharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2023.
  • Navidea Biopharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2023 was -186 %, a 24% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 -186 +58.9 +24% Sep 30, 2023
Q2 2023 -182 +458 +71.5% Jun 30, 2023
Q1 2023 -152 -476 -147% Mar 31, 2023
Q4 2022 -177 -333 -213% Dec 31, 2022
Q3 2022 -245 -384 -276% Sep 30, 2022
Q2 2022 -640 -821 -454% Jun 30, 2022
Q1 2022 324 -296 -47.7% Mar 31, 2022
Q4 2021 156 +961 Dec 31, 2021
Q3 2021 139 +512 Sep 30, 2021
Q2 2021 181 +498 Jun 30, 2021
Q1 2021 621 +1.69K Mar 31, 2021
Q4 2020 -805 +2.12K +72.5% Dec 31, 2020
Q3 2020 -373 -1.11K -151% Sep 30, 2020
Q2 2020 -317 -774 -170% Jun 30, 2020
Q1 2020 -1.07K -1.56K -320% Mar 31, 2020
Q4 2019 -2.93K -3.25K -995% Dec 31, 2019
Q3 2019 734 +550 +299% Sep 30, 2019
Q2 2019 456 +352 +337% Jun 30, 2019
Q1 2019 487 +409 +523% Mar 31, 2019
Q4 2018 327 +274 +518% Dec 31, 2018
Q3 2018 184 +918 Sep 30, 2018
Q2 2018 104 +290 Jun 30, 2018
Q1 2018 78.1 +214 Mar 31, 2018
Q4 2017 52.9 +170 Dec 31, 2017
Q3 2017 -734 -615 -518% Sep 30, 2017
Q2 2017 -185 -62.8 -51.2% Jun 30, 2017
Q1 2017 -136 -5.01 -3.82% Mar 31, 2017
Q4 2016 -117 +17.2 +12.8% Dec 31, 2016
Q3 2016 -119 +18.6 +13.5% Sep 30, 2016
Q2 2016 -123 +20.9 +14.5% Jun 30, 2016
Q1 2016 -131 +21.5 +14.1% Mar 31, 2016
Q4 2015 -134 +52.2 +28% Dec 31, 2015
Q3 2015 -137 +117 +46.1% Sep 30, 2015
Q2 2015 -143 +393 +73.3% Jun 30, 2015
Q1 2015 -153 +1.28K +89.3% Mar 31, 2015
Q4 2014 -186 -44.9K -100% Dec 31, 2014
Q3 2014 -255 -3.83K -107% Sep 30, 2014
Q2 2014 -536 +1.76K +76.6% Jun 30, 2014
Q1 2014 -1.43K -2.02K -342% Mar 31, 2014
Q4 2013 44.7K +44.6K +26121% Dec 31, 2013
Q3 2013 3.57K +3.49K +4123% Sep 30, 2013
Q2 2013 -2.29K -2.34K -4959% Jun 30, 2013
Q1 2013 592 +548 +1249% Mar 31, 2013
Q4 2012 171 Dec 31, 2012
Q3 2012 84.5 Sep 30, 2012
Q2 2012 47.2 Jun 30, 2012
Q1 2012 43.9 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.